维普中文期刊产品整合服务
73篇 您的检索式:作者名="Trinchet"
    题名 作者 年代 出处 被引量
1Liver insulin-like growth factor 2 methylation in hepatitis C virus cirrhosis and further occurrence of hepatocellular carcinoma显示文摘AIM: To assess the predictive value of the insulinlike growth factor 2 (Igf2) methylation profile for the occurrence of Hepatocellular Carcinoma (HCC) in hepatitis C (HCV) cirrhosis. METHODS: Patients with: (1) biopsy-proven compensated HCV cirrhosis; (2) available baseline frozen liver sample; (3) absence of detectable HCC; (4) regular screening for HCC; (5) informed consent for genetic analysis were studied. After DNA extraction from liver samples and bisulfite treatment, unbiased PCR and DHPLC analysis were performed for methylation analysis at the Igf2 locus. The predictive value of the Igf2 methylation profile for HCC wasassessed by Kaplan-Meier and Cox methods. RESULTS: Among 94 included patients, 20 developed an HCC during follow-up (6.9 ± 3.2 years). The methylation profile was hypomethylated, intermediate and hypermethylated in 13, 64 and 17 cases, respectively. In univariate analysis, two baseline parameters were associated with the occurrence of HCC: age (P = 0.01) and prothrombin (P = 0.04). The test of linear tendency between the three ordered levels of Igf2 methylation and probability of HCC occurrence was significant (Log Rank, P = 0.043; Breslow, P = 0.037; Tarone-Ware, P = 0.039). CONCLUSION: These results suggest that hypomethylation at the Igf2 locus in the liver could be predictive for HCC occurrence in HCV cirrhosis.Philippe Couvert Alain Carrié Jacques Pariès Jenny Vaysse Audrey Miroglio Antoine Kerjean Pierre Nahon Jamel Chelly Jean-Claude Trinchet Michel Beaugrand Nathalie Ganne-Carrié 2008World Journal of Gastroenterology2008,14,35:6
2Impact of Metformin on the Prognosis of Cirrhosis Induced by Viral Hepatitis C in Diabetic Patients显示文摘Gisèle Nkontchou Emmanuel Cosson Mounir Aout Amel Mahmoudi Valérie Bourcier Iliass Charif Nathalie Ganne-Carrie Véronique Grando-Lemaire Eric Vicaut Jean-Claude Trinchet Michel Beaugrand 2011The Journal of Clinical Endocrinology & Metabolism2011,,8:3
3Effect of sustained virological response on long-term clinical outcome in 113 patients with compensated hepatitis C-related cirrhosis treated by interferon alpha and ribavirin显示文摘AIM:To assess the long-term clinical benefit of sustained virological response(SVR)in patients with hepatitis C virus(HCV)cirrhosis treated by antiviral therapy using mostly ribavirin plus interferon either standard or pegylated.METHODS:One hundred and thirteen patients with uncomplicated HCV biopsy-proven cirrhosis,treated by at least one course of antiviral treatment ≥ 3 mo and followed ≥ 30 mo were included.The occurrence of clinical events hepatocellular carcinoma(HCC),decompensation and death was compared in SVR and non SVR patients.RESULTS:Seventy eight patients received bitherapy and 63 had repeat treatments.SVR was achieved in 37 patients(33%).During a mean follow-up of 7.7 years,clinical events occurred more frequently in non SVR than in SVR patients,with a significant difference for HCC(24/76 vs 1/37,P = 0.01).No SVR patient died while 20/76 non-SVR did(P = 0.002),mainly in relation to HCC(45%).CONCLUSION:In patients with HCV-related cirrhosis,SVR is associated with a significant decrease in the incidence of HCC and mortality during a follow-up period of 7.7 years.This result is a strong argument to perform and repeat antiviral treatments in patients with compensated cirrhosis.Roland El Braks Nathalie Ganne-Carrié Hélène Fontaine Jacques Paries Véronique Grando-Lemaire Michel Beaugrand Stanislas Pol Jean-Claude Trinchet 2007World Journal of Gastroenterology2007,13,42:3
4Risk Factors for Hepatocellular Carcinoma in Patients With Alcoholic or Viral C Cirrhosis显示文摘Gisèle N’Kontchou Jacques Paries Myint Tin Tin Htar Nathalie Ganne–Carrie Lydie Costentin Véronique Grando–Lemaire Jean–Claude Trinchet Michel Beaugrand 2006Clinical Gastroenterology and Hepatology2006,,8:2
5PNPLA3 rs738409, hepatocellular carcinoma occurrence and risk model prediction in patients with cirrhosis显示文摘Erwan Guyot Angela Sutton Pierre Rufat Christelle Laguillier Abdellah Mansouri Richard Moreau Nathalie Ganne-Carrié Michel Beaugrand Nathalie Charnaux Jean-Claude Trinchet Pierre Nahon 2012Journal of Hepatology2012,,:2
6A new prognostic classification for predicting survival in patients with hepatocellular carcinoma显示文摘Sylvie Chevret Jean-Claude Trinchet Didier Mathieu Antoine Abou Rached Michel Beaugrand Claude Chastang 1999Journal of Hepatology1999,,1:2
7Assessment of liver fibrosis using transient elastography in patients with alcoholic liver disease显示文摘Pierre Nahon Adrien Kettaneh Iulia Tengher-Barna Marianne Ziol Victor de Lédinghen Catherine Douvin Patrick Marcellin Nathalie Ganne-Carrié Jean-Claude Trinchet Michel Beaugrand 2008Journal of Hepatology2008,,6:1
8Treatment of hepatocellular carcinoma in patients with cirrhosis显示文摘Trinchet JC Beaugrand M 1997J Hepatol1997,27,4:1
9Hepatic iron over- load and risk of hepatocellular carcinoma in cirrhosis显示文摘Nahon P Ganne-Carri N Trinchet JC 2010Gastro- enterol Clin Biol2010,34,1:1
10Prospective study of screening for hepatocellular carcinoma in Caucasian patients with cirrhosis显示文摘Pateron D Ganne N Trinchet JC 1994J Hepatol1994,20,:1
11Systemic treatment of hepatocellular carcinoma 显示文摘Ganne-Carrie N Trinchet JC 2004Eur J Gastroenterol Hepatol2004,16,3:1
12Insulin resistance is associated with a higher risk of hepatocellular carcinoma in cirrhotic HIV/HCV-co-infected patients: Results from ANRS CO13 HEPAVIH显示文摘Dominique Salmon Firouzé Bani-Sadr Marc-Arthur Loko Hind Stitou Anne Gervais Jacques Durant Eric Rosenthal Yann Quertainmont Karl Barange Daniel Vittecoq Michka Shoai-Tehrani Muriel Alvarez Maria Winnock Jean Claude Trinchet Fran?ois Dabis Philippe Sogni 2011Journal of Hepatology2011,,4:1
13Pathological modifications following sub-chronic exposure of medaka fish(Oryzias latipes) to microcystin-LR显示文摘Trinchet I Djediat C Huet H 2011Reproductive Toxicology2011,32,3:1
14Systemic treatment of hepatocellular carcinoma显示文摘Ganne-Carrie N Trinchet JC 2004Eur J Gastroenterol Hepatol2004,16,3:1
15Genetic risk markers for hepatocellular carcinoma in patients with alcoholic liver disease显示文摘Pierre Nahon Angela Sutton Marianne Ziol Jessica Zucman-Rossi Jean-Claude Trinchet Nathalie Ganne-Carrié 2015Hepat. Oncol2015,,1:1
16Hepatocellular carcinoma in patients with hepatitis C virus-related chronic liver disease显示文摘Hepatitis C virus (HCV) is a major cause of hepatocellular carcinoma (HCC) worldwide due to the high prevalence of HCV infection and the high rate of HCC occurrence in patients with HCV cirrhosis. A striking increase in HCC incidence has been observed during the past decades in most industrialized countries, partly related to the growing number of patients infected by HCV. HCC is currently the main cause of death in patients with HCV-related cirrhosis, a fact that justifies screening as far as curative treatments apply only in patients with small tumors. As a whole, treatment options are similar in patients with cirrhosis whatever the cause. Chemoprevention could be also helpful in the near future. It is strongly suggested that antiviral treatment of HCV infection could prevent HCC occurrence, even in cirrhotic patients, mainly when a sustained virological response is obtained.Jean-Claude Trinchet Nathalie Ganne-Carrié Pierre Nahon Gisèle N’kontchou Michel Beaugrand 2007World Journal of Gastroenterology2007,13,17:1
17Systemic antibiotic therapy prevents bacteria infection in cirrhotic patients with gastrointestinal hemorrhage显示文摘Blaise M Pateron D Trinchet JC 1994Hepatology1994,20,1:1
18Prospective study of screening for hepatocellular carcinoma in Caucasion patients with cirrhosis显示文摘PATERON D GANNE N TRINCHET J C 1994J Hepatol1994,20,1:1
19Prospective study of screening for hepatocellular carcinoma in Cauca- sian patients with cirrhosis显示文摘Pateron D Ganne N Trinchet J C 1994J Hepatol1994,20,1:1
20Risk Factors for Hepatocellular Carcinoma in Patients With Alcoholic or Viral C Cirrhosis显示文摘Gisèle N’Kontchou Jacques Paries Myint Tin Tin Htar Nathalie Ganne–Carrie Lydie Costentin Véronique Grando–Lemaire Jean–Claude Trinchet Michel Beaugrand 2006Clinical Gastroenterology and Hepatology2006,,8:1
返回顶部 每页显示:
共4页 首页 上一页 第1页 下一页 末页 /4 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费